Wide variance in safety indicator drug monitoring by GP practices in England and Wales revealed in new data

Drug and medical device knowledge company, First Databank (FDB) is urging GP practices to standardise their approaches to routine testing and monitoring of drugs, after its data revealed variance in compliance across key safety indicators for drug prescriptions.